He would stand up, with open eyes, and he would struggle and toil and learn until, with eyes unblinded
and tongue untied, he could share with her his visioned wealth.
The flames from Castra Regis and from Diana's Grove made all around almost as light as day, and now that the lightning had ceased to flash, their eyes, unblinded
, were able to judge both perspective and detail.
I speak with heartfelt sincerity," he says, "and I think unblinded
judgment, when I tell you that I feel a little man by his side.
We look forward to the outcome of our planned unblinded
interim analysis for the HONOR study in the first half of 2018, with topline results expected in the second half of 2018 for the full study, if needed.
The agency's permission is based on data reviewed from a multisite, unblinded
12-week clinical trial sponsored by the National Institute on Drug Abuse of 399 patients who received either standard treatment or standard treatment with the addition of a desktop-based version of reSET.
The action was taken by the company after consultation with the Independent Data Monitoring Committee and a review of the unblinded
data of the trial, named CASCADE.
Medivir AB (STO:MVIR) announced on Wednesday that the independent Data Monitoring Committee (DMC) held its fourth and final scheduled meeting and recommended continuation of the ongoing randomised, double-blind phase IIa study (MIV-711-201) based on a review of unblinded
Gilead Sciences' Phase III Study evaluating Zydelig (idelalisib) added to standard therapy in previously-treated chronic lymphocytic leukemia (CLL) will be unblinded
early following the recommendation by an independent Data Monitoring Committee (DMC) based on a interim analysis indicating a statistically significant benefit in efficacy for progression-free survival (PFS) and overall survival (OS).
The study was unblinded
in August 2015, and a full report of the primary outcome measures will come in a paper due out by the end of the year, they said.
The Data Safety and Monitoring Board (DSMB), a committee of international experts, reviewed unblinded
safety and efficacy data from CHART-1 and determined that such data did not support discontinuation of the trial on the basis of safety or futility and recommended that it continue without changes to the protocol.
An earlier, unblinded
RCT randomized 40 infants (mean age 14 days) with ankyloglossia and breastfeeding problems to frenotomy or lactation support.
The phase 3 study was unblinded
midway, allowing patients receiving the placebo to instead take the drug because of the favorable results.